Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Compounded amlexanox capsules are prescription-only oral formulations prepared for patients who may benefit from targeted modulation of chronic inflammation and metabolic imbalance. Research shows that amlexanox inhibits the protein kinases TBK1 and IKKε, pathways associated with inflammatory signaling, insulin resistance, energy expenditure, and metabolic regulation. Through these mechanisms, amlexanox may support improvements in systemic inflammation, insulin sensitivity, fatty liver physiology, blood glucose regulation, and metabolic wellness in select patients, particularly those exhibiting features of metabolic syndrome such as elevated visceral fat, poor glycemic control, oxidative stress, and increased CRP levels. A subset of patients appear especially responsive, and emerging clinical experience suggests that, in carefully selected individuals, amlexanox therapy may complement broader metabolic care strategies; in some cases, clinicians may also consider combining amlexanox with low-dose naltrexone (LDN) to further support immune modulation and inflammatory balance under prescriber supervision. Our pharmacy compounds amlexanox capsules in customized strengths and dosing strategies to align with prescriber-directed therapeutic goals, offering a precision-tailored option for patients seeking advanced support for chronic inflammation and metabolic health.
Patients? Request More Information Prescribers? Request Prescribing Access
Compounded amlexanox capsules are prescription-only oral formulations prepared for patients who may benefit from targeted modulation of chronic inflammation and metabolic imbalance. Research shows that amlexanox inhibits the protein kinases TBK1 and IKKε, pathways associated with inflammatory signaling, insulin resistance, energy expenditure, and metabolic regulation. Through these mechanisms, amlexanox may support improvements in systemic inflammation, insulin sensitivity, fatty liver physiology, blood glucose regulation, and metabolic wellness in select patients, particularly those exhibiting features of metabolic syndrome such as elevated visceral fat, poor glycemic control, oxidative stress, and increased CRP levels. A subset of patients appear especially responsive, and emerging clinical experience suggests that, in carefully selected individuals, amlexanox therapy may complement broader metabolic care strategies; in some cases, clinicians may also consider combining amlexanox with low-dose naltrexone (LDN) to further support immune modulation and inflammatory balance under prescriber supervision. Our pharmacy compounds amlexanox capsules in customized strengths and dosing strategies to align with prescriber-directed therapeutic goals, offering a precision-tailored option for patients seeking advanced support for chronic inflammation and metabolic health.
Patients? Request More Information Prescribers? Request Prescribing Access
